Abstract
In a small group of hypertensive patients studied at home, once daily early morning sotalol therapy effectively decreased lying, standing, and post-exercise blood pressure and pulse rate. A dose-response relationship was seen. Adverse effects were mild and transient. The once daily regimen is easy to administer and appears to give precision in blood pressure reduction. Providing there is no subsequent escape from control, once daily beta-blocking therapy should aid long-term hypertension treatment in general practice.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blackwell B. Drug therapy: patient compliance. N Engl J Med. 1973 Aug 2;289(5):249–252. doi: 10.1056/NEJM197308022890506. [DOI] [PubMed] [Google Scholar]
- Brown P., Baddeley H., Read A. E., Davies J. D., McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. doi: 10.1016/s0140-6736(74)90218-9. [DOI] [PubMed] [Google Scholar]
- Douglas-Jones A. P., Cruickshank J. M. Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J. 1976 Apr 24;1(6016):990–991. doi: 10.1136/bmj.1.6016.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Felix R. H., Ive F. A., Dahl M. G. Cutaneous and ocular reactions to practolol. Br Med J. 1974 Nov 9;4(5940):321–324. doi: 10.1136/bmj.4.5940.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gatley M. S. To be taken as directed. J R Coll Gen Pract. 1968 Jul;16(1):39–44. [PMC free article] [PubMed] [Google Scholar]
- Gross F. Drug therapy of hypertension: what we have, what we need, what we expect. Am J Cardiol. 1974 Oct 1;34(4):471–475. doi: 10.1016/0002-9149(74)90016-2. [DOI] [PubMed] [Google Scholar]
- Harris A. M., Wollard K. V., Tweed J. A. A study of once daily tenormin (atenolol) in hypertension: some implications in patient compliance. J Int Med Res. 1976;4(5):347–351. doi: 10.1177/030006057600400508. [DOI] [PubMed] [Google Scholar]
- Lish P. M., Weikel J. H., Dungan K. W. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):161–173. [PubMed] [Google Scholar]
- PRICHARD B. N., GILLAM P. M. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. doi: 10.1136/bmj.2.5411.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petrie J. C. Diseases of the cardiovascular system. Hypertension--I. Br Med J. 1976 Jul 31;2(6030):289–291. doi: 10.1136/bmj.2.6030.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simpson F. O. Beta-adrenergic receptor blocking drugs in hypertension. Drugs. 1974;7(1):85–105. doi: 10.2165/00003495-197407010-00006. [DOI] [PubMed] [Google Scholar]
- Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J. 1975 Mar 15;1(5958):595–598. doi: 10.1136/bmj.1.5958.595. [DOI] [PMC free article] [PubMed] [Google Scholar]